nanotech investing TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
nanotech investing Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
nanotech investing Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
nanotech investing U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
nanotech investing Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
nanotech investing Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office
nanotech investing Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
nanotech investing Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
nanotech investing MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
nanotech investing Nuvation Bio Announces IBTROZI® Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
nanotech investing Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
nanotech investing Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib's Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer
nanotech investing Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026
TomaGold Announces Closing of First Tranche of Private Placement Featuring Strategic Investment from SIDEX and NQIM
